Graypoint LLC Raises Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Graypoint LLC lifted its position in UnitedHealth Group Incorporated (NYSE:UNH) by 9.1% in the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 8,998 shares of the healthcare conglomerate’s stock after purchasing an additional 749 shares during the quarter. Graypoint LLC’s holdings in UnitedHealth Group were worth $5,261,000 at the end of the most recent quarter.

A number of other hedge funds also recently bought and sold shares of the company. Delta Financial Group Inc. grew its stake in shares of UnitedHealth Group by 1.0% in the 3rd quarter. Delta Financial Group Inc. now owns 1,650 shares of the healthcare conglomerate’s stock worth $965,000 after buying an additional 17 shares in the last quarter. Signature Resources Capital Management LLC increased its stake in UnitedHealth Group by 40.0% during the second quarter. Signature Resources Capital Management LLC now owns 63 shares of the healthcare conglomerate’s stock worth $32,000 after acquiring an additional 18 shares during the last quarter. Saxony Capital Management LLC boosted its holdings in shares of UnitedHealth Group by 3.5% in the 2nd quarter. Saxony Capital Management LLC now owns 530 shares of the healthcare conglomerate’s stock worth $270,000 after purchasing an additional 18 shares during the period. GoalVest Advisory LLC raised its holdings in UnitedHealth Group by 0.6% during the 2nd quarter. GoalVest Advisory LLC now owns 3,124 shares of the healthcare conglomerate’s stock valued at $1,591,000 after buying an additional 18 shares during the period. Finally, Fiduciary Group LLC boosted its stake in UnitedHealth Group by 0.5% during the second quarter. Fiduciary Group LLC now owns 3,695 shares of the healthcare conglomerate’s stock worth $1,882,000 after buying an additional 18 shares during the period. Institutional investors own 87.86% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently issued reports on UNH shares. Truist Financial restated a “buy” rating and issued a $625.00 target price (down previously from $640.00) on shares of UnitedHealth Group in a report on Wednesday, October 16th. HSBC lowered UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Thursday, October 17th. Hsbc Global Res lowered UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a research note on Thursday, October 17th. Cantor Fitzgerald increased their target price on UnitedHealth Group from $591.00 to $644.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 16th. Finally, UBS Group cut their price target on shares of UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating on the stock in a report on Wednesday, October 16th. Four research analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and two have issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $615.53.

UnitedHealth Group Trading Up 5.2 %

Shares of NYSE UNH opened at $596.69 on Thursday. The business has a fifty day moving average price of $581.13 and a 200 day moving average price of $543.74. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $608.63. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.91 and a quick ratio of 0.88. The stock has a market capitalization of $551.00 billion, a P/E ratio of 38.87, a price-to-earnings-growth ratio of 1.64 and a beta of 0.58.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $7.00 by $0.15. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The firm had revenue of $100.82 billion for the quarter, compared to the consensus estimate of $99.14 billion. During the same quarter in the previous year, the firm earned $6.56 EPS. The company’s quarterly revenue was up 9.2% compared to the same quarter last year. Equities research analysts expect that UnitedHealth Group Incorporated will post 27.61 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th will be issued a $2.10 dividend. This represents a $8.40 annualized dividend and a yield of 1.41%. UnitedHealth Group’s dividend payout ratio is presently 54.72%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.